3 recalls found for STAQ Pharma. Check if any of your products are affected.
STAQ Pharma Inc. recalled Ketamine Hydrochloride 50mg/5 mL syringes on October 9, 2025. The recall affects products with incorrect or missing lot and expiration dates. The FDA classified this recall as Class III due to potential risks to patient safety.
STAQ Pharma Inc. recalled Hydromorphone HCL PF injections on October 9, 2025, due to incorrect or missing lot and expiration dates. The recall affects products distributed nationwide across the U.S. Healthcare providers and consumers must immediately cease using the affected medication.
STAQ Pharma Inc. recalled FentaNYL Citrate PF on October 9, 2025, due to incorrect or missing lot and expiration dates. The injection, distributed nationwide, poses a high hazard risk. Consumers and healthcare providers should stop using the product immediately.